1-acetyl-lysergic acid diethylamide, also known as ALD-52 or Orange Sunshine Acid, is a LSD-analogue non-regulated by law.Buy 100x 1A-LSD (ALD-52) 100mcg Online 24/7. 100x 1A-LSD (ALD-52) 100mcg For Sale Online 24/7. Buy LSD Online 24/7
As it is a homologue to 1P-LSD it is much comparable to LSD-25. With the introduction of ALD-52 onto the fine chemical market researchers can intensify their research about lysergamides.
We currently stock 1A-LSD (ALD-52) in the form of 100µg blotters for research purposes.
Buy 100x 1A-LSD (ALD-52) 100mcg Online 24/7. 100x 1A-LSD (ALD-52) 100mcg For Sale Online 24/7
Methylisopropyllysergamide (lysergic acid methylisopropyl amide, MIPLA) is an analogue of LSD that was originally discovered by Albert Hofmann at Sandoz during the original structure-activity research into LSD. It has subsequently been investigated in more detail by the team led by David E. Nichols at Purdue University. Methylisopropyllysergamide is a structural isomer of LSD, with the alkyl groups on the amide nitrogen having been subjected to a methylene shuffle. MIPLA and its ethylisopropyl homologue are the only simple N,N-dialkyl lysergamides that approach the potency of LSD itself, being around 1/3-1/2 the potency of LSD, while all other dialkyl analogues tested (dimethyl, dipropyl, methylethyl etc.) are only around 1/10 as potent as LSD, although some N-monoalkyl lysergamides such as the sec-butyl and t-butyl derivatives were also found to show an activity profile and potency comparable to LSD, and the mono-isopropyl derivative is only slightly weaker than MIPLA. Apart from its lower potency, the hallucinogenic effects of methylisopropyllysergamide are similar to those of LSD itself, and the main use for this drug has been in studies of the binding site at the 5-HT2A receptor through which LSD exerts most of its pharmacological effects. Buy 100x 1A-LSD (ALD-52) 100mcg Online 24/7. 100x 1A-LSD (ALD-52) 100mcg For Sale Online 24/7
Buy LSD Online 24/7
Lysergic acid 2-butyl amide (2-Butyllysergamide, LSB) is an analogue of LSD originally developed by Richard Pioch at Eli Lilly in the 1950s, but mostly publicised through research conducted by the team led by David E. Nichols at Purdue University. It is a structural isomer of LSD, with the two ethyl groups on the amide nitrogen having been replaced by a single sec-butyl group, joined at the 2-position. It is one of the few lysergamide derivatives to exceed the potency of LSD in animal drug discrimination assays, with the (R) isomer having an ED50 of 33nmol/kg for producing drug-appropriate responding, vs 48nmol/kg for LSD itself. The corresponding (R)-2-pentyl analogue has higher binding affinity for the 5-HT1A and 5-HT2A receptors, but is less potent in producing drug-appropriate responding, suggesting that the butyl compound has a higher efficacy at the receptor target. The drug discrimination assay for LSD in rats involves both 5-HT1A and 5-HT2A mediated components, and while lysergic acid 2-butyl amide is more potent than LSD as a 5-HT1A agonist, it is slightly less potent as a 5-HT2A agonist, and so would probably be slightly less potent than LSD as a hallucinogen in humans. The main use for this drug has been in studies of the binding site at the 5-HT2A receptor through which LSD exerts most of its pharmacological effects, with the stereoselective activity of these unsymmetric monoalkyl lysergamides foreshadowing the subsequent development of compounds such as lysergic acid 2,4-dimethylazetidide (LSZ). Buy 100x 1A-LSD (ALD-52) 100mcg Online 24/7. 100x 1A-LSD (ALD-52) 100mcg For Sale Online 24/7